Literature DB >> 28406729

Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Robert D Kendig1, Fumitake Kai1, Elizabeth A Fry1, Kazushi Inoue1.   

Abstract

We recently reported the existence of a physical interaction between the Myb-like transcription factor Dmp1 (Dmtf1) and p53 in which Dmp1 antagonized polyubiquitination of p53 by Mdm2 and promoted its nuclear localization. Dmp1 significantly stabilized p53-DNA complexes on promoters that contained p53-consensus sequences, which were either supershifted or disrupted with antibodies to Dmp1. Lysates from mice injected with doxorubicin showed that Dmp1 bound to p21Cip1, Bbc3, and Thbs1 gene regulatory regions in a p53-dependent fashion. Our data suggest that acceleration of DNA-binding of p53 by Dmp1 is a critical process for Dmp1 to increase the p53 function in Arf-deficient cells.

Entities:  

Keywords:  Bbc3; Cancer; Chromatin immunoprecipitation; DNA binding; Dmp1 (Dmtf1); Electrophoretic mobility shift assay (EMSA); Knockout; Mdm2; Thbs1; Transcription; p21Cip1; p53

Mesh:

Substances:

Year:  2017        PMID: 28406729      PMCID: PMC6262109          DOI: 10.1080/07357907.2017.1303505

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  85 in total

1.  Regulation of mutant p53 temperature-sensitive DNA binding.

Authors:  P Friedlander; Y Legros; T Soussi; C Prives
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

2.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

3.  Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas.

Authors:  K Inoue; F Zindy; D H Randle; J E Rehg; C J Sherr
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

Review 4.  The regulation of INK4/ARF in cancer and aging.

Authors:  William Y Kim; Norman E Sharpless
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

Review 5.  Regulation of tumor angiogenesis by thrombospondin-1.

Authors:  Bin Ren; Karen O Yee; Jack Lawler; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2005-12-21

6.  Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Takayuki Sugiyama; Robert D Kendig; Donna P Frazier; Mark C Willingham; Kazushi Inoue
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

7.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.

Authors:  Sinan Zhu; Ryan T Mott; Elizabeth A Fry; Pankaj Taneja; George Kulik; Guangchao Sui; Kazushi Inoue
Journal:  Am J Pathol       Date:  2013-08-11       Impact factor: 4.307

9.  Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.

Authors:  Takayuki Sugiyama; Donna P Frazier; Pankaj Taneja; Robert D Kendig; Rachel L Morgan; Lauren A Matise; Sarah J Lagedrost; Kazushi Inoue
Journal:  Clin Med Oncol       Date:  2008-04-01

10.  Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.

Authors:  Kwan-Hyuck Baek; Dongha Bhang; Alexander Zaslavsky; Liang-Chuan Wang; Anil Vachani; Carla F Kim; Steven M Albelda; Gerard I Evan; Sandra Ryeom
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

View more
  4 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  Aberrant Expression of p14ARF in Human Cancers: A New Biomarker?

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Tumor Microenviron       Date:  2019-02-04

3.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

4.  Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53.

Authors:  Elizabeth A Fry; Gloria E Niehans; Robert A Kratzke; Fumitake Kai; Kazushi Inoue
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.